Status:
UNKNOWN
Genetic and Epigenetic Risk of T2D in the UAE
Lead Sponsor:
Imperial College London Diabetes Centre
Conditions:
Diabetes Mellitus, Type 2
Obesity
Eligibility:
All Genders
18-70 years
Brief Summary
T2D is a global public health crisis and a threat to socioeconomic development of all nations, particularly in developing countries. Countries in the Gulf region, including the UAE, have some of the h...
Detailed Description
The general aim of my research will be to investigate the contribution of environmental, genetic, and epigenetic factors to the increased risk of T2D in the Emirati population compared to Europeans. M...
Eligibility Criteria
Inclusion
- Fasted for at least 8 hrs
- Arab-Emiati ethnicity
- Males and Females
- Diagnosed with prediabetes OR
- Diagnosed with type 2 diabetes OR
- Have normal glucose tolerance
Exclusion
- Other types of diabetes
- Undergone a recent surgical operation that hinders them from carrying out their normal day to day chores
Key Trial Info
Start Date :
March 23 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04270097
Start Date
March 23 2016
End Date
December 1 2022
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imperial College London Diabetes Centre
Abu Dhabi, United Arab Emirates, 48338